• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Percutaneous coronary intervention in left main disease: 10-year follow-up.

作者信息

Kobayashi Akihiro, Misumida Naoki

机构信息

Banner University Medical Center Phoenix, Department of Cardiology, Phoenix, AZ, USA.

Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.

出版信息

Ann Transl Med. 2019 Mar;7(5):85. doi: 10.21037/atm.2019.01.05.

DOI:10.21037/atm.2019.01.05
PMID:31019935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6462650/
Abstract
摘要

相似文献

1
Percutaneous coronary intervention in left main disease: 10-year follow-up.左主干病变的经皮冠状动脉介入治疗：10年随访
Ann Transl Med. 2019 Mar;7(5):85. doi: 10.21037/atm.2019.01.05.
2
Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.多支血管病变或左主干病变患者经皮介入治疗后的监测压力测试。
J Am Coll Cardiol. 2024 Mar 5;83(9):890-900. doi: 10.1016/j.jacc.2023.12.027.
3
Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干冠状动脉疾病的比较？一项随机对照试验的系统评价和荟萃分析。
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12260.
4
Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease.左主干病变经皮冠状动脉介入治疗后靶病变血运重建对长期死亡率的影响。
JACC Cardiovasc Interv. 2024 Jan 8;17(1):32-42. doi: 10.1016/j.jcin.2023.10.068.
5
Chronic Kidney Disease and Post-Percutaneous Coronary Intervention Mortality in Patients With Left Main and Equivalent Coronary Artery Disease.慢性肾脏病与左主干及等效冠状动脉疾病患者经皮冠状动脉介入治疗后死亡率。
Tex Heart Inst J. 2022 Sep 1;49(5). doi: 10.14503/THIJ-21-7670.
6
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.比较单纯血管造影方法与紫杉醇经皮冠状动脉介入治疗和心脏手术评分方法在左主干冠状动脉支架置入中的协同作用：系列 PRECOMBAT（使用依维莫司洗脱支架在左主干冠状动脉疾病患者中进行旁路手术与血管成形术的随机比较的首项研究）的汇总分析。
Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374.
7
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗三血管病变或左主干病变患者：多中心随机对照 SYNTAX 试验 10 年随访结果。
Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2.
8
A comparative study of bypass versus percutaneous intervention for left main disease.左主干病变搭桥术与经皮介入治疗的对比研究。
Tunis Med. 2019 Apr;97(4):533-540.
9
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗 3 支血管病变或左主干病变患者的成本效益：紫杉醇药物洗脱支架与心脏手术（SYNTAX）试验的最终结果。
Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
10
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease.多支血管病变及无保护左主干冠状动脉疾病患者冠状动脉旁路移植术与第二代药物洗脱支架经皮冠状动脉介入治疗的结果
SAGE Open Med. 2017 Jan 18;5:2050312116687707. doi: 10.1177/2050312116687707. eCollection 2017.

本文引用的文献

1
Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.冠状动脉疾病患者中三种不同聚合物涂层雷帕霉素洗脱支架的十年临床结果研究。
Circulation. 2019 Jan 15;139(3):325-333. doi: 10.1161/CIRCULATIONAHA.118.038065.
2
10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.左主干冠状动脉疾病中支架与冠状动脉旁路移植术的 10 年结果比较。
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2813-2822. doi: 10.1016/j.jacc.2018.09.012. Epub 2018 Sep 24.
3
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.新型经皮冠状动脉血运重建术治疗初发三血管病变患者的临床结局：SYNTAX II 研究 1 年结果。
Eur Heart J. 2017 Nov 7;38(42):3124-3134. doi: 10.1093/eurheartj/ehx512.
4
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较：系统评价和荟萃分析。
JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.
5
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄（NOBLE）：一项前瞻性、随机、开放标签、非劣效性试验。
Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31.
6
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.依维莫司洗脱支架或旁路移植术治疗左主干冠状动脉疾病。
N Engl J Med. 2016 Dec 8;375(23):2223-2235. doi: 10.1056/NEJMoa1610227. Epub 2016 Oct 31.
7
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的冠状动脉搭桥手术
N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3.
8
Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.左主干支架置入术与外科血运重建术的比较：（左主干冠状动脉支架置入术）勒芒试验的10年结果
JACC Cardiovasc Interv. 2016 Feb 22;9(4):318-327. doi: 10.1016/j.jcin.2015.10.044.
9
Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.随机试验：左主干冠状动脉疾病中支架治疗与旁路手术的比较：PRECOMBAT 研究 5 年结果。
J Am Coll Cardiol. 2015 May 26;65(20):2198-206. doi: 10.1016/j.jacc.2015.03.033. Epub 2015 Mar 15.
10
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组编写，欧洲经皮心血管介入协会（EAPCI）提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.